Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscription Services
Submission Forms
Place an Ad
Weather
News
Sports/Outdoors
Calendar
Promote Your Event
Obituaries
Photos
Videos
Classifieds
Place an ad
E-Edition
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Fulcrum Therapeutics Inc
(NQ:
FULC
)
7.950
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Sep 23, 2022
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
7.950
Bid (Size)
7.350 (1)
Ask (Size)
9.920 (1)
Prev. Close
7.950
Today's Range
7.950 - 7.950
52wk Range
3.210 - 29.12
Shares Outstanding
41,009,442
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
Top News
More News
U.S. Stock Futures Edge Lower Ahead Of Walmart, Home Depot Earnings
August 16, 2022
Pre-open movers
Via
Benzinga
Walmart, Home Depot And 3 Stocks To Watch Heading Into Tuesday
August 16, 2022
With US stock futures trading slightly lower this morning on Tuesday, some of the stocks that may grab investor focus today are as follows:
Via
Benzinga
Performance
YTD
-55.39%
-55.39%
1 Month
+10.42%
+10.42%
3 Month
+52.30%
+52.30%
6 Month
-61.24%
-61.24%
1 Year
-70.84%
-70.84%
More News
Read More
Recap: Fulcrum Therapeutics Q2 Earnings
August 11, 2022
Via
Benzinga
Fulcrum Therapeutics Earnings Preview
August 10, 2022
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
July 12, 2022
Via
Benzinga
4 Analysts Have This to Say About Fulcrum Therapeutics
June 13, 2022
Via
Benzinga
Analyst Ratings for Fulcrum Therapeutics
May 17, 2022
Via
Benzinga
Recap: Fulcrum Therapeutics Q1 Earnings
May 09, 2022
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
July 11, 2022
Via
Benzinga
10 Biggest Price Target Changes For Monday
June 13, 2022
Via
Benzinga
Mid-Afternoon Market Update: Dow Drops Over 600 Points; Fulcrum Therapeutics Shares Tumble
June 10, 2022
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
June 10, 2022
Via
Benzinga
91 Biggest Movers From Friday
June 13, 2022
Via
Benzinga
Mid-Day Market Update: Nasdaq Dips 400 Points; Cogent Biosciences Shares Jump
June 10, 2022
Via
Benzinga
44 Stocks Moving In Friday's Mid-Day Session
June 10, 2022
Via
Benzinga
Mid-Morning Market Update: Markets Open Lower; US Inflation Rate Accelerates to 8.6%
June 10, 2022
Via
Benzinga
Looking Into Fulcrum Therapeutics's Return On Capital Employed
June 03, 2022
Via
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
June 01, 2022
Via
Benzinga
Earnings Preview: Fulcrum Therapeutics
May 06, 2022
Via
Benzinga
Fulcrum Therapeutics Earnings Conference Call Is Coming Up, Here's What You Need To Know
May 04, 2022
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
April 13, 2022
Via
Benzinga
The Daily Biotech Pulse: Thervance Gains On Positive Late-Stage Readout, Bristol-Myers Squibb Snags 3 Approvals In Europe, Decision Day For BioXcel
April 05, 2022
Via
Benzinga
The Week Ahead In Biotech (April 3-April 9): BioXcel FDA Decision, Neurology Conference Presentations Take The Spotlight
April 03, 2022
Via
Benzinga
Fulcrum Therapeutics's Return On Capital Employed Overview
March 09, 2022
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 8, 2022
March 08, 2022
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
